Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease
Foteini Korkida, Alexandra Stamatopoulou, Maria G. Roubelakis
Stem Cells Translational Medicine (2023) Vol. 13, Iss. 2, pp. 107-115
Open Access | Times Cited: 10

Showing 10 citing articles:

Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities
Bárbara M. Silva, José Bragança
World Journal of Stem Cells (2025) Vol. 17, Iss. 2
Closed Access
The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease
Dandan Qin, Pingping Huang, Jialing Chen, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Cell therapy for end-stage liver disease: Current state and clinical challenge
Lin Zhang, Youbin Deng, Xue‐Song Bai, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Enhanced In Vitro Recapitulation of In Vivo Liver Regeneration by Co-Culturing Hepatocyte Organoids with Adipose-Derived Mesenchymal Stem Cells, Alleviating Steatosis and Apoptosis in Acute Alcoholic Liver Injury
Sun A Ock, Seo-yeon Kim, Young-Im Kim, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1303-1303
Open Access | Times Cited: 1
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion
Caifeng Zhang, Juanjuan Ji, Xue-Fang Du, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Nutritional and microbiota-based therapeutic intervention for alcohol-associated liver disease: Pathogenesis to therapeutic insights
Shagun Rangra, Dhwani Rana, Arvee Prajapati, et al.
Life Sciences (2024) Vol. 352, pp. 122852-122852
Closed Access
Advances in Mesenchymal Stem Cell Therapy and Natural Antioxidants for Hepatic Fibrosis: A Comprehensive Review
Abeer Kazmi, Tahira Sultana
Deleted Journal (2024) Vol. 2, pp. 100016-100016
Closed Access
Mesenchymal stem cells: A promising therapeutic avenue for non-alcoholic fatty liver disease
Chun‐Han Cheng, Wen‐Rui Hao, Tzu-Hurng Cheng
World Journal of Stem Cells (2024) Vol. 16, Iss. 8, pp. 780-783
Closed Access
Innovative mesenchymal stem cell treatments for fatty liver disease
Fei-Qiong Gao, Jiaqi Zhu, Xudong Feng
World Journal of Stem Cells (2024) Vol. 16, Iss. 9, pp. 846-853
Closed Access
Innovative Strategies for Liver Transplantation: The Role of Mesenchymal Stem Cells and Their Cell-Free Derivatives
Miho Akabane, Yuki Imaoka, Jun Kawashima, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1604-1604
Open Access
Page 1

Scroll to top